Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jwfoley
    Senior Member
    • Jun 2009
    • 183

    #1

    Statistical comparison of more than two ChIP-seq experiments

    I have a peaks × experiments matrix of tag counts from ChIP-seq experiments in several conditions (with replicates), and I want to know which peaks are differentially enriched in different conditions. Basically, for each row of the matrix, I want to do an ANOVA (or something equivalent) asking if the enrichment is the same in all classes or not. Of course, I need to transform the raw counts in some way first.

    Does anyone know how to do this rigorously? I know DESeq, edgeR, and DEGseq are designed for this kind of analysis, but as far as I can tell they only support a two-class comparison. Is there a way I can use them to compare more than two classes? Would it be appropriate just to use their variance stabilizations etc. to transform my data, then replace their two-class test with an ANOVA?

    Also, each of my experiments has its own total chromatin control, so each control is a separate column in my matrix. Can these programs use ChIP-seq controls in some way, or are they only really for RNA-seq?
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    Hi

    I have just added a new functionality to DESeq which allows you to fit generalized linear models (GLMs), in order to support more complex contrasts than simple comparisons. I am currently testing and documenting it and will release it soon.

    Your application to ChIP-Seq was one of the use cases I had in mind for this GLM functionalioty but I could not try this out yet for lack of suitable data. As you have replicates and even per-sample input controls, your data might be a great test case. I'd be very interested to hear more details.

    Cheers
    Simon

    Comment

    • jwfoley
      Senior Member
      • Jun 2009
      • 183

      #3
      Thanks. That sounds perfect. I'd be very interested in trying it as soon as it's available, even if it's not fully documented, since I have a meeting coming up and would like to have preliminary results to discuss.

      I can give you an example of my data if that would help. Let me know how to send it to you.

      Comment

      • idonaldson
        Member
        • Oct 2009
        • 37

        #4
        I have a related question that i recently asked of the bioconductor forum. Should the ChIP-seq reads used for making the count tables be filtered to remove redundant reads (i.e. those mapping to exactly the same position)?

        Comment

        • jwfoley
          Senior Member
          • Jun 2009
          • 183

          #5
          That question would be better off in a brand-new thread than a year-old one, but even better is to see whether anyone's asked it already. Here's one previous incarnation of it: http://seqanswers.com/forums/showthread.php?t=6543
          Last edited by jwfoley; 10-19-2011, 01:32 PM.

          Comment

          • Boel
            Member
            • Oct 2009
            • 62

            #6
            jwfoley,
            I have some data coming in which were produced in a very similar setting. How did you end up analyzing your data? Do you have any references for where similar comparisons have been made?
            Thanks!

            Comment

            • jwfoley
              Senior Member
              • Jun 2009
              • 183

              #7
              I developed a new method that is not yet publicly available, but I'm hoping to submit the manuscript within the next month or two and will make the method available once the paper is accepted. For the statistical analysis, I used DESeq.

              Comment

              • Boel
                Member
                • Oct 2009
                • 62

                #8
                Originally posted by jwfoley View Post
                I developed a new method that is not yet publicly available, but I'm hoping to submit the manuscript within the next month or two and will make the method available once the paper is accepted. For the statistical analysis, I used DESeq.
                Haha.. OK, good for you. Hope things go smooth with the manuscript.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                  by SEQadmin2



                  CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                  Despite this, “CRISPR helped turn genome editing from a specialized technique into
                  ...
                  07-31-2026, 11:01 AM
                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 07:41 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 08-03-2026, 10:13 AM
                0 responses
                25 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-31-2026, 02:55 AM
                0 responses
                38 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                25 views
                0 reactions
                Last Post SEQadmin2  
                Working...